0.3192
+0.0007
+(0.22%)
At close: April 10 at 4:00:03 PM EDT
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Dr. Robert Alexander Ph.D. | CEO & Director | 1.5M | -- | 1970 |
| Dr. Adam L. Tomasi Ph.D. | President | 1.15M | -- | 1970 |
| Mr. Alan Chang | Director of Medical Affairs & Data Analytics | -- | -- | -- |
Allakos Inc.
825 Industrial Road
Suite 500
San Carlos, CA 94070
United States
- Sector:
- Healthcare
- Industry: Biotechnology
Description
Allakos Inc., a clinical stage biotechnology company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases in the United States. The company was incorporated in 2012 and is headquartered in San Carlos, California.
Corporate Governance
Allakos Inc.’s ISS Governance QualityScore as of April 1, 2025 is 10. The pillar scores are Audit: 5; Board: 10; Shareholder Rights: 8; Compensation: 10.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
May 7, 2025 at 10:59 AM UTC - May 12, 2025 at 12:00 PM UTC
Allakos Inc. Earnings Date
Recent Events
Related Tickers
RLMD Relmada Therapeutics, Inc.
0.2860
+10.51%
MRSN Mersana Therapeutics, Inc.
0.2614
-13.90%
IKNA Ikena Oncology, Inc.
1.0600
-3.64%
CLRB Cellectar Biosciences, Inc.
0.2728
+11.03%
HLVX HilleVax, Inc.
1.5500
+0.65%
GBIO Generation Bio Co.
0.3490
-6.31%
ELEV Elevation Oncology, Inc.
0.2700
+3.85%
NKGN NKGen Biotech, Inc.
0.1104
-8.00%
NXTC NextCure, Inc.
0.2700
-7.66%
STOK Stoke Therapeutics, Inc.
6.52
+1.40%